glp 1 and thyroid disease glp-1 issues and thyroid issues Why GLP-1 Agonists Are Risky For Thyroid Weight Loss-de More Thyroid Cancers Found After

Ageing Res Rev 2022:101636

ZEPBOUND **General Notes:**- All listed drugs are administered as once-weekly subcutaneous injections.- Off-label use for weight loss has been common for Ozempic and Mounjaro prior to the approval of Wegovy and Zepbound for obesity.- Dosages vary by patient needs and indication but typically start at lower doses and are titrated up.- Main risks under emerging research include potential severe vision complications (e.g., NAION) in addition to commonly known side effects

This protective mechanism is especially valuable for sensitive compounds such as Vitamin C, glutathione, curcumin, and resveratrolnutrients known for their instability in traditional delivery systems

127 PatkeA.YoungM

In such a situation, one of the largest obstacles is that most of the GLP-1 receptor antibodies which are available now are not working very well in several experiments including immunostaining and western blotting